2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗

2017-12-28 欧洲儿科胃肠病学、肝病学和营养协会 J Pediatr Gastroenterol Nutr. 2017 Dec 28.

2017年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童慢性丙肝感染的治疗意见书,本文主要涉及儿童慢性丙肝感染治疗管理的相关内容,包括治疗目标,适应证和禁忌证以及最佳治疗方案等。

中文标题:

2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗

英文标题:

Treatment of Chronic Hepatitis C Virus Infection in Children. A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

发布日期:

2017-12-28

简要介绍:

2017年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童慢性丙肝感染的治疗意见书,本文主要涉及儿童慢性丙肝感染治疗管理的相关内容,包括治疗目标,适应证和禁忌证以及最佳治疗方案等。

 

拓展指南:丙肝相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗)] GetToolGuiderByIdResponse(projectId=1, id=f36541c0015a0175, title=2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗, enTitle=Treatment of Chronic Hepatitis C Virus Infection in Children. A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition., guiderFrom=J Pediatr Gastroenterol Nutr. 2017 Dec 28., authorId=null, author=, summary=2017年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童慢性丙肝感染的治疗意见书,本文主要涉及儿童慢性丙肝感染治疗管理的相关内容,包括治疗目标,适应证和禁忌证以及最佳治疗方案等。 , cover=, journalId=null, articlesId=null, associationId=515, associationName=欧洲儿科胃肠病学、肝病学和营养协会, associationIntro=欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)是一个专业和科学的为任何我们服务的患者和他们的家庭寻找护理标准的协会。, copyright=0, guiderPublishedTime=Thu Dec 28 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童慢性丙肝感染的治疗意见书,本文主要涉及儿童慢性丙肝感染治疗管理的相关内容,包括治疗目标,适应证和禁忌证以及最佳治疗方案等。 </P> <P> </P>拓展指南:<strong>与<font color=red>丙肝</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=18ccf1c001a41e99" title="2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理" target=_blank>2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5f5c01c001386500" title="2017 ILTS共识声明:肝移植受者丙肝的管理" target=_blank>2017 ILTS共识声明:肝移植受者丙肝的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a34341c00138a84f" title="2017 ILTS共识声明:肝移植候选者丙肝管理" target=_blank>2017 ILTS共识声明:肝移植候选者丙肝管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=141cf1c0013192ff" title="2016 ACOG委员会意见:妇产科医师乙肝,丙肝和艾滋病毒感染(No.655)" target=_blank>2016 ACOG委员会意见:妇产科医师乙肝,丙肝和艾滋病毒感染(No.655)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f5091c001215292" title="2015 AASLD-IDSA丙肝指南:成人丙型肝炎感染的检测,管理和治疗建议" target=_blank>2015 AASLD-IDSA丙肝指南:成人丙型肝炎感染的检测,管理和治疗建议</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B8%99%E8%82%9D" target=_blank>有关丙肝更多指南</a></ul>, tagList=[TagDto(tagId=1138, tagName=儿童), TagDto(tagId=33783, tagName=慢性丙肝感染)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4127, appHits=108, showAppHits=0, pcHits=3063, showPcHits=1281, likes=103, shares=4, comments=4, approvalStatus=1, publishedTime=Fri Jan 05 22:23:52 CST 2018, publishedTimeString=2017-12-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 05 22:23:52 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 02:06:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗)])
2017 ESPGHAN意见书:儿童慢性丙肝感染的治疗
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=890960, encodeId=987e89096045, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc0c2071567, createdName=1871f037efm, createdTime=Sat Oct 10 09:23:55 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349981, encodeId=75d8349981e1, content=目前国家已进口丙肝特效药索磷布韦,就是有点小贵,愿这个好消息能帮到更多的丙肝患者!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/20/c3c2d5ecac5e792e100a6ba487b657f7.jpg, createdBy=8a972419003, createdName=神奇的印度(丙肝特效/肿瘤靶向), createdTime=Sat Oct 20 18:58:24 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278819, encodeId=e01d2e8819dc, content=学习了.非常好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A255C84C7CC905B7A536F1089C7CFA96/100, createdBy=526a2034359, createdName=竹颜, createdTime=Mon Jan 15 21:00:23 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276292, encodeId=065f2e6292ae, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jan 07 09:08:21 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2020-10-10 1871f037efm

    积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=890960, encodeId=987e89096045, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc0c2071567, createdName=1871f037efm, createdTime=Sat Oct 10 09:23:55 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349981, encodeId=75d8349981e1, content=目前国家已进口丙肝特效药索磷布韦,就是有点小贵,愿这个好消息能帮到更多的丙肝患者!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/20/c3c2d5ecac5e792e100a6ba487b657f7.jpg, createdBy=8a972419003, createdName=神奇的印度(丙肝特效/肿瘤靶向), createdTime=Sat Oct 20 18:58:24 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278819, encodeId=e01d2e8819dc, content=学习了.非常好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A255C84C7CC905B7A536F1089C7CFA96/100, createdBy=526a2034359, createdName=竹颜, createdTime=Mon Jan 15 21:00:23 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276292, encodeId=065f2e6292ae, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jan 07 09:08:21 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-10-20 神奇的印度(丙肝特效/肿瘤靶向)

    目前国家已进口丙肝特效药索磷布韦,就是有点小贵,愿这个好消息能帮到更多的丙肝患者!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=890960, encodeId=987e89096045, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc0c2071567, createdName=1871f037efm, createdTime=Sat Oct 10 09:23:55 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349981, encodeId=75d8349981e1, content=目前国家已进口丙肝特效药索磷布韦,就是有点小贵,愿这个好消息能帮到更多的丙肝患者!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/20/c3c2d5ecac5e792e100a6ba487b657f7.jpg, createdBy=8a972419003, createdName=神奇的印度(丙肝特效/肿瘤靶向), createdTime=Sat Oct 20 18:58:24 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278819, encodeId=e01d2e8819dc, content=学习了.非常好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A255C84C7CC905B7A536F1089C7CFA96/100, createdBy=526a2034359, createdName=竹颜, createdTime=Mon Jan 15 21:00:23 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276292, encodeId=065f2e6292ae, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jan 07 09:08:21 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-15 竹颜

    学习了.非常好!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=890960, encodeId=987e89096045, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc0c2071567, createdName=1871f037efm, createdTime=Sat Oct 10 09:23:55 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=349981, encodeId=75d8349981e1, content=目前国家已进口丙肝特效药索磷布韦,就是有点小贵,愿这个好消息能帮到更多的丙肝患者!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/20/c3c2d5ecac5e792e100a6ba487b657f7.jpg, createdBy=8a972419003, createdName=神奇的印度(丙肝特效/肿瘤靶向), createdTime=Sat Oct 20 18:58:24 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278819, encodeId=e01d2e8819dc, content=学习了.非常好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A255C84C7CC905B7A536F1089C7CFA96/100, createdBy=526a2034359, createdName=竹颜, createdTime=Mon Jan 15 21:00:23 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276292, encodeId=065f2e6292ae, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jan 07 09:08:21 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0